Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Pulmonary Circulation|May 4, 2022
Elective lower limb orthopedic arthroplasty surgery in patients with pulmonary hypertensionMikaela Wardle, Amanda Nair, Sarah Saunders, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|May 14, 2025
Selection of patient-reported outcome measures in pulmonary arterial hypertension clinical trials: a systematic review, meta-analysis and health-related quality of life frameworkFrances Varian, Rebecca Burney, Charlotte Pearson, et al.
Respirology (Carlton, Vic.)|September 29, 2022
Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension: A Bayesian retrospective observational cohort studyTimothy J W Dawes, Colm McCabe, Konstantinos Dimopoulos, et al.
The European Respiratory Journal|July 6, 2023
Establishing minimally important differences for cardiac MRI end-points in pulmonary arterial hypertensionSamer Alabed, Pankaj Garg, Faisal Alandejani, et al.
BMC Medicine|September 29, 2017
Towards new recommendations to reduce the burden of alcohol-induced hypertension in the European UnionJürgen Rehm, Peter Anderson, Jose Angel Arbesu Prieto, et al.
British Journal of Anaesthesia|February 22, 2021
Perioperative management of patients with pulmonary hypertension undergoing non-cardiothoracic, non-obstetric surgery: a systematic review and expert consensus statementLaura C Price, Guillermo Martinez, Aimee Brame, et al.
Respirology (Carlton, Vic.)|July 4, 2025
NT-proBNP and BNP Testing in Pulmonary Arterial Hypertension: Point-of-Care and Remote MonitoringCharlotte Durrington, Christian Battersby, Laura Holt, et al.
Lancet (London, England)|December 5, 2017
Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UKRoger Williams, Graeme Alexander, Iain Armstrong, et al.
Lancet (London, England)|December 4, 2019
Unacceptable failures: the final report of the Lancet Commission into liver disease in the UKRoger Williams, Guruprasad Aithal, Graeme J Alexander, et al.
Pulmonary Circulation|March 19, 2024
Pulmonary Hypertension: Intensification and Personalization of Combination Rx (PHoenix): A phase IV randomized trial for the evaluation of dose-response and clinical efficacy of riociguat and selexipag using implanted technologiesFrances Varian, Jennifer Dick, Christian Battersby, et al.
Pageof 6